ARCHIVES

Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014

NCI Cooperative Group Clinical Trials Approved

May 29, 2009

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

Turmoil in Texas: SEC Issues Subpoena to AVEO on Tivozanib

July 12, 2013

DCPC advisors OK New Grant Programs In Tobacco, Rural Area

November 12, 1993

Youth Smoking Linked To Exposure In Movies

December 30, 2005